Coronary provocative testing with acetylcholine (Ach) for the contemporary diagnosis of epicardial and microvascular spasm is a safe procedure with excellent safety records in Western studies; however, heterogeneity still exists because of the lack of a standardized provocation protocol and complication reporting, a new meta-analysis of clinical data concludes.